Literature DB >> 28765088

The evolving role of ankyrin-B in cardiovascular disease.

Sara N Koenig1, Peter J Mohler2.   

Abstract

Over the past decade, ankyrin-B has been identified as a prominent player in cardiac physiology. Ankyrin-B has a multitude of functions, with roles in expression, localization, and regulation of proteins critical for cardiac excitability, cytoskeletal integrity, and signaling. Furthermore, human ANK2 variants that result in ankyrin-B loss of function are associated with "ankyrin-B syndrome," a complex cardiac phenotype that may include bradycardia and heart rate variability, conduction block, atrial fibrillation, QT interval prolongation, and potentially fatal catecholaminergic polymorphic ventricular tachycardia. However, our understanding of the molecular mechanisms underlying ankyrin-B function at baseline and in disease is still not fully developed owing to the complexity of ankyrin-B gene regulation, number of ankyrin-B-associated molecules, multiple roles of ankyrin-B in the heart and other organs that modulate cardiac function, and a host of unexpected clinical phenotypes. In this review, we summarize known roles of ankyrin-B in the heart and the impact of ankyrin-B dysfunction in animal models and in human disease as well as highlight important new findings illustrating the complexity of ankyrin-B signaling.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ANK2; Ankyrin-B; Arrhythmias; Channelopathy; Ion channel

Mesh:

Substances:

Year:  2017        PMID: 28765088      PMCID: PMC5712256          DOI: 10.1016/j.hrthm.2017.07.032

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  72 in total

Review 1.  Modeling of cardiac electrophysiological mechanisms: from action potential genesis to its propagation in myocardium.

Authors:  A L Bardou; P M Auger; P J Birkui; J L Chassé
Journal:  Crit Rev Biomed Eng       Date:  1996

2.  Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.

Authors:  Roseanne M Wolf; Patric Glynn; Seyed Hashemi; Keyan Zarei; Colleen C Mitchell; Mark E Anderson; Peter J Mohler; Thomas J Hund
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-22       Impact factor: 4.733

3.  Identification and characterization of two ankyrin-B isoforms in mammalian heart.

Authors:  Henry C Wu; Gokay Yamankurt; JiaLie Luo; Janani Subramaniam; Syed Shahrukh Hashmi; Hongzhen Hu; Shane R Cunha
Journal:  Cardiovasc Res       Date:  2015-06-24       Impact factor: 10.787

4.  440-kD ankyrinB: structure of the major developmentally regulated domain and selective localization in unmyelinated axons.

Authors:  W Chan; E Kordeli; V Bennett
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

5.  Ankyrin-B regulates Kir6.2 membrane expression and function in heart.

Authors:  Jingdong Li; Crystal F Kline; Thomas J Hund; Mark E Anderson; Peter J Mohler
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

6.  Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes.

Authors:  Mari Ichikawa; Takeshi Aiba; Seiko Ohno; Daichi Shigemizu; Junichi Ozawa; Keiko Sonoda; Megumi Fukuyama; Hideki Itoh; Yoshihiro Miyamoto; Tatsuhiko Tsunoda; Takeru Makiyama; Toshihiro Tanaka; Wataru Shimizu; Minoru Horie
Journal:  Circ J       Date:  2016-10-25       Impact factor: 2.993

7.  Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes.

Authors:  Peter J Mohler; Woohyun Yoon; Vann Bennett
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

8.  Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.

Authors:  Solena Le Scouarnec; Naina Bhasin; Claude Vieyres; Thomas J Hund; Shane R Cunha; Olha Koval; Celine Marionneau; Biyi Chen; Yuejin Wu; Sophie Demolombe; Long-Sheng Song; Hervé Le Marec; Vincent Probst; Jean-Jacques Schott; Mark E Anderson; Peter J Mohler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

9.  Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

Authors:  Niels Voigt; Jordi Heijman; Qiongling Wang; David Y Chiang; Na Li; Matthias Karck; Xander H T Wehrens; Stanley Nattel; Dobromir Dobrev
Journal:  Circulation       Date:  2013-11-18       Impact factor: 29.690

10.  Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.

Authors:  Peter J Mohler; Ilaria Rivolta; Carlo Napolitano; Guy LeMaillet; Stephen Lambert; Silvia G Priori; Vann Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-03       Impact factor: 11.205

View more
  12 in total

1.  Casein Kinase 1δ Stabilizes Mature Axons by Inhibiting Transcription Termination of Ankyrin.

Authors:  Matthew L LaBella; Edward J Hujber; Kristin A Moore; Randi L Rawson; Sean A Merrill; Patrick D Allaire; Michael Ailion; Julie Hollien; Michael J Bastiani; Erik M Jorgensen
Journal:  Dev Cell       Date:  2020-01-06       Impact factor: 12.270

Review 2.  Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease.

Authors:  Nicole S York; Juan C Sanchez-Arias; Alexa C H McAdam; Joel E Rivera; Laura T Arbour; Leigh Anne Swayne
Journal:  Front Cardiovasc Med       Date:  2022-08-04

3.  The Postmortem Interpretation of Cardiac Genetic Variants of Unknown Significance in Sudden Death in the Young: A Case Report and Review of the Literature.

Authors:  Saleh Fadel; Alfredo E Walker
Journal:  Acad Forensic Pathol       Date:  2021-03-17

4.  Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation.

Authors:  Wengen Zhu; Cen Wang; Jinzhu Hu; Rong Wan; Jianhua Yu; Jinyan Xie; Jianyong Ma; Linjuan Guo; Jin Ge; Yumin Qiu; Leifeng Chen; Hualong Liu; Xia Yan; Xiuxia Liu; Jin Ye; Wenfeng He; Yang Shen; Chao Wang; Peter J Mohler; Kui Hong
Journal:  Circulation       Date:  2018-12-04       Impact factor: 29.690

Review 5.  Caveolin-3 Microdomain: Arrhythmia Implications for Potassium Inward Rectifier and Cardiac Sodium Channel.

Authors:  Ravi Vaidyanathan; Louise Reilly; Lee L Eckhardt
Journal:  Front Physiol       Date:  2018-11-09       Impact factor: 4.566

6.  Ankyrin B and Ankyrin B variants differentially modulate intracellular and surface Cav2.1 levels.

Authors:  Catherine S W Choi; Ivana A Souza; Juan C Sanchez-Arias; Gerald W Zamponi; Laura T Arbour; Leigh Anne Swayne
Journal:  Mol Brain       Date:  2019-09-02       Impact factor: 4.041

Review 7.  Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.

Authors:  Holly C Sucharski; Emma K Dudley; Caullin B R Keith; Mona El Refaey; Sara N Koenig; Peter J Mohler
Journal:  Biomolecules       Date:  2020-01-31

8.  Transcriptomic uniqueness and commonality of the ion channels and transporters in the four heart chambers.

Authors:  Sanda Iacobas; Bogdan Amuzescu; Dumitru A Iacobas
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

9.  T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B.

Authors:  Agustin Garcia-Caballero; Fang-Xiong Zhang; Victoria Hodgkinson; Junting Huang; Lina Chen; Ivana A Souza; Stuart Cain; Jennifer Kass; Sascha Alles; Terrance P Snutch; Gerald W Zamponi
Journal:  Mol Brain       Date:  2018-05-02       Impact factor: 4.041

10.  Downregulation of miR-146a Contributes to Cardiac Dysfunction Induced by the Tyrosine Kinase Inhibitor Sunitinib.

Authors:  Li Shen; Congxin Li; Hua Zhang; Suhua Qiu; Tian Fu; Yanfang Xu
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.